These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
68 related articles for article (PubMed ID: 2585946)
1. [Evaluation of clinical efficacy of rifampicin in the treatment of nontuberculous mycobacteriosis from in vitro susceptibility testing]. Tsukamura M Kekkaku; 1989 Jul; 64(7):453-8. PubMed ID: 2585946 [TBL] [Abstract][Full Text] [Related]
2. [Evaluation of cycloserine in the treatment of infections caused by nontuberculous mycobacteria viewed from in vitro experiments]. Tsukamura M Kekkaku; 1989 May; 64(5):345-9. PubMed ID: 2507817 [TBL] [Abstract][Full Text] [Related]
3. [Evaluation of clinical efficacy of isoniazid and ethambutol in the treatment of nontuberculous mycobacteriosis based on in vitro susceptibility testing]. Tsukamura M Kekkaku; 1989 Aug; 64(8):511-8. PubMed ID: 2811008 [TBL] [Abstract][Full Text] [Related]
4. [Sulfadimethoxine as a promising drug in the treatment of infections caused by Mycobacterium kansasii and Mycobacterium xenopi--differentiation between M. kansasii and M. marinum and between M. gordonae and M. scrofulaceum by the susceptibility testing to sulfadimethoxine]. Tsukamura M Kekkaku; 1989 Apr; 64(4):313-7. PubMed ID: 2747117 [TBL] [Abstract][Full Text] [Related]
5. [Study of the minimal inhibitory concentration of rifabutine (Ansamycin LM 427) for Mycobacterium tuberculosis, Mycobacterium xenopi and Mycobacterium avium-intracellulare]. Truffot-Pernot C; Giroir AM; Maury L; Grosset J Rev Mal Respir; 1988; 5(4):401-6. PubMed ID: 2845531 [TBL] [Abstract][Full Text] [Related]
6. [In vitro susceptibility testing of nontuberculous mycobacteria to streptomycin, kanamycin and enviomycin]. Tsukamura M Kekkaku; 1989 Sep; 64(9):557-62. PubMed ID: 2554046 [TBL] [Abstract][Full Text] [Related]
7. [Antimycobacterial susceptibility against nontuberculous mycobacteria using brothmic NTM]. Kawata N; Kawahara S; Tada A; Takigawa N; Shibayama T; Soda R; Takahashi K Kekkaku; 2006 Apr; 81(4):329-35. PubMed ID: 16715941 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of a newly developed broth microdilution test method to determine minimum inhibitory concentrations (MICs) of antimicrobial agents for mycobacteria]. Yamane N; Nakasone I; Saitoh H; Kaneda M; Shimojima M; Yamashita K; Toyoda K; Okazawa Y Rinsho Byori; 1998 Jul; 46(7):719-27. PubMed ID: 9721542 [TBL] [Abstract][Full Text] [Related]
9. [A supplement study on the in vitro activity of sulfadimethoxine on Mycobacterium avium complex--combined effect with other antituberculosis drugs]. Tsukamura M Kekkaku; 1989 Jun; 64(6):379-86. PubMed ID: 2507819 [TBL] [Abstract][Full Text] [Related]
10. [Cross-resistance relationships of antituberculosis drugs in Mycobacterium avium complex]. Tsukamura M Kekkaku; 1989 Jan; 64(1):1-5. PubMed ID: 2709652 [TBL] [Abstract][Full Text] [Related]
11. [Nontuberculous mycobacteriosis; the present status and in the future. 3--(1). The view of development of new drugs against nontuberculous mycobacterial infections]. Kawahara S; Nagare H Kekkaku; 1998 Feb; 73(2):77-82. PubMed ID: 9545700 [TBL] [Abstract][Full Text] [Related]
12. [Bactericidal activities of rifampicin, ethambutol, enviomycin and streptomycin on Mycobacterium avium-Mycobacterium intracellulare complex strains]. Tsukamura M; Yamori S Kekkaku; 1990 Aug; 65(8):519-25. PubMed ID: 2214513 [TBL] [Abstract][Full Text] [Related]
13. [Combination of gentamycin and amikacin with rifampicin, ethambutol and isoniazid on selected standard strains of Mycobacterium species in experiments done in vitro and in vivo]. Janowiec M; Andrzejczyk Z; Marczewska J Pneumonol Pol; 1989 May; 57(5):300-7. PubMed ID: 2633149 [TBL] [Abstract][Full Text] [Related]
14. [Effectiveness of the combined therapy of pulmonary mycobacterial infections depending on the species classification of the causative agent]. Kochetov BI; Deviatova AI Ter Arkh; 1987; 59(7):80-2. PubMed ID: 3118493 [TBL] [Abstract][Full Text] [Related]
15. [Chemotherapeutic regimens for nontuberculous mycobacterial infection based on in-vitro susceptibility test results]. Tsukamura M; Yamori S Kekkaku; 1990 May; 65(5):349-57. PubMed ID: 2168003 [TBL] [Abstract][Full Text] [Related]
16. [Radiometric determination of Mycobacterium avium-intracellulare and Mycobacterium xenopi sensitivity to antitubercular agents]. Kubín M; Lindholm-Levy P; Heifets LB Epidemiol Mikrobiol Imunol; 1994 Sep; 43(3):104-6. PubMed ID: 7953081 [TBL] [Abstract][Full Text] [Related]
17. [Drug susceptibility test for Mycobacterium tuberculosis using non-radioactive substance, alpha-antigen]. Shigeto E; Taska H Kekkaku; 1996 Mar; 71(3):245-52. PubMed ID: 8901226 [TBL] [Abstract][Full Text] [Related]
18. [Clinical studies on lung disease caused by atypical mycobacteria in our hospital--especially in relation to drug susceptibility]. Mineshita M; Miyazawa T; Doi M; Suei S; Matsuura M; Senoo T; Yamakido M Kekkaku; 1993 Jul; 68(7):479-86. PubMed ID: 8361116 [TBL] [Abstract][Full Text] [Related]
19. [Utility of the direct culture examination (Ziehl-Neelsen) using the Bactec system for the presumptive identification of Mycobacterium tuberculosis complex, Mycobacterium avium complex, Mycobacterium xenopi, and Mycobacterium kansasii]. Moreno C; Garrigó M; Sánchez F; Coll P Enferm Infecc Microbiol Clin; 1994 May; 12(5):241-5. PubMed ID: 7811323 [TBL] [Abstract][Full Text] [Related]
20. Mycobacterium resistance to antimycobacterial reagent. Aghandous R; Zouhdi M; Zizi M; Errami M; Idrissi L Therapie; 1999; 54(5):623-5. PubMed ID: 10667100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]